The global infection surveillance solutions market is projected to reach USD 1,100 million by 2027 from USD 577 million in 2022, at a CAGR of 13.8% during the forecast period. Growth in this market is predominantly driven by the increasing prevalence of hospital-acquired infections and new Medicare policies, including non-payment for hospital-acquired conditions. The rising number of surgeries, the growing geriatric population, the increasing incidence of chronic diseases, and increasing adoption of antimicrobial stewardship programs are the other factors driving the growth of this market. However, data breaches, and lack of skilled analysts are expected to hamper the growth of this market during the forecast period to a certain extent.
Prominent players in the global infection surveillance solutions market include Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and VIZZIA Technologies (US). These companies adopted strategies such as product launches/enhancements, expansions, agreements, partnerships, collaborations, sales contracts, investments, joint ventures, and acquisitions to strengthen their market presence in the infection surveillance solutions market. Recently, new smaller competitors have emerged from niche markets and are challenging larger companies by offering lower prices and technological advancements. To remain competitive, major market players are focusing on expanding into fast-growing emerging markets and acquiring smaller companies with favorable technological capabilities or geographic presence
To know about the assumptions considered for the study download the pdf brochure
Becton, Dickinson and Company is a global medical technology company engaged in developing, manufacturing, and selling a broad range of medical supplies, devices, laboratory equipment, and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical companies, and the general public. The company operates through three major segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Life Sciences segment comprises organizational units—Integrated Diagnostic Solutions and Biosciences. The company offers infection surveillance solutions through its Integrated Diagnostic Solutions unit. BD has more than 77,000 associates serving more than 190 countries. Its products are manufactured and sold across Europe, EMA (which includes the Commonwealth of the Independent States, the Middle East, and Africa), Greater Asia (which includes countries in Greater China, Japan, South Asia, Southeast Asia, South Korea, Australia, and New Zealand), Latin America, and Canada. BD HealthSight Infection Advisor, BD MedMind Insights, and BD HealthSight Clinical Advisor are the major infection surveillance software developed and marketed by the company. BD significantly invests in R&D activities to add technologically innovative solutions to its portfolio and collaborations, which helps it to strengthen its market presence.
Premier, Inc. is a healthcare performance improvement company uniting an alliance of approximately 3,600 US hospitals and 120,000 other healthcare providers. The company offers integrated data and analytics, supply chain solutions, and advisory and other services to transform healthcare and enable better care and outcomes at a lower cost. The company partners with hospitals, health systems, physicians, employers, product suppliers, service providers, and other healthcare providers and organizations. Premier operates through two business segments: Supply Chain Services and Performance Services. The company offers infection surveillance solutions under the Performance Services business segment, which includes PremierConnect Surveillance & Safety, Infection Control Assistant, SafetyAdvisor, PINC AI Remote Surveillance, and TheraDoc infection surveillance software. The company focuses on product launches/enhancements, agreements, partnerships, collaborations, and acquisitions to increase its share in the infection surveillance solutions market.
Infection Surveillance Solutions Market by Software (On-Premise, Web-Based), Services (Product Support & Maintenance, Implementation, Training & Consulting), End User (Hospitals, Long-Term Care Facilities), and Region- Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE